Safety of unconventional antibody-drug conjugate L-DOS47 in a phase I/II monotherapy study targeting advanced NSCLC

20251 citationsJournal Articlegold Open Access

Authors

https://www.clinicaltrialsregister.eu/ctr-search/search; EudraCT Identifier: 2010-020729-42 (May 6, 2010).

Good health and well-being

Published in: Frontiers in Oncology

Volume 15, pp. 1544967-1544967

Field-Weighted Citation Impact: 0.98